Last reviewed · How we verify
CVL006 Injection
At a glance
| Generic name | CVL006 Injection |
|---|---|
| Also known as | B006, No other name |
| Sponsor | Convalife (Shanghai) Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2) (PHASE1, PHASE2)
- CVL006 Combination Therapy in Advanced Solid Tumors (PHASE1, PHASE2)
- Clinical Study of CVL006 Injection in Advanced Solid Tumors (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |